← Evidence map

ArticleBlood2019

Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas.

Raphael Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30498064